The Conversation (0)
Reuters reported last Friday that Amgen Inc., (NASDAQ:AMGN) the world’s largest biotech company, has offered to buy biotech Onyx Pharmaceuticals (NASDAQ:ONXX) for $120 per share in cash.
Reuters reported last Friday that Amgen Inc., (NASDAQ:AMGN) the world’s largest biotech company, has offered to buy biotech Onyx Pharmaceuticals (NASDAQ:ONXX) for $120 per share in cash.
As quoted in the market news:
The Financial Post said that documents it had seen said that Amgen had sent material to Onyx in which it said it would propose a cash acquisition worth about $10 billion and requested due diligence and a document review period.